HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-pos...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
Melanoma highlights from ESMO 2019 ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
30 Sep 2019
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
Important developments in radiation oncology ( Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA )
26 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain me...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
Gene expression in primary non-small cell lung cancer as a predictor of brain metastases ( Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Are PARP inhibitors a new standard of care option for MBC patients?
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
Are PARP inhibitors a new standard of care option for MBC patients? ( Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston, USA )
18 Jun 2019
Potential of PARP inhibitors for metastatic breast cancer
Dr Alexandra Zimmer - National Cancer Institute, Bethesda, USA
Potential of PARP inhibitors for metastatic breast cancer ( Dr Alexandra Zimmer - National Cancer Institute, Bethesda, USA )
3 Jun 2019
Artificial intelligence and treatment decisions
Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA
Artificial intelligence and treatment decisions ( Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA )
24 May 2019
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Dr Mark Litzow - Mayo Clinic, Rochester, USA
CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019
Future directions in glioblastoma: the potential role of TKIs
Prof Roger Stupp, Dr Giuseppe Lombardi
Future directions in glioblastoma: the potential role of TKIs ( Prof Roger Stupp, Dr Giuseppe Lombardi )
9 May 2019
Anti-cancer compound for brain cancer found in daffodils
Dr Lorenzo Caggiano - University of Bath, Bath, UK
Anti-cancer compound for brain cancer found in daffodils ( Dr Lorenzo Caggiano - University of Bath, Bath, UK )
2 May 2019
Current treatment for brain tumours
Prof Mark Beresford - Royal United Hospital Bath, Bath, UK
Current treatment for brain tumours ( Prof Mark Beresford - Royal United Hospital Bath, Bath, UK )
2 May 2019